Armata Pharmaceuticals VP Richard Rychlik Departs with Benefits

Armata Pharmaceuticals ( (ARMP) ) has shared an update.

Armata Pharmaceuticals, Inc. has announced the departure of its Vice President, Richard Rychlik, with the end of his employment slated for September 30, 2024. Rychlik will receive his base salary and subsidized health benefits until the end of the year as part of a Confidential Separation and Release Agreement, conditioned on his adherence to the agreement’s terms.

For detailed information about ARMP stock, go to TipRanks’ Stock Analysis page.